Lesson 3.2: Heart Failure, Arrhythmias, and Valvular Disease

Introduction

In this lesson, we will explore heart failure, arrhythmias, and valvular disease, focusing on their diagnosis, staging, and management. Understanding these conditions is vital as they frequently present in clinical practice, especially in acute and chronic settings. By the end of this lesson, students will be able to:

• Differentiate between systolic and diastolic heart failure, including their diagnosis, staging, and guideline-directed therapy.
• Recognize common tachyarrhythmias and bradyarrhythmias, including atrial fibrillation, and make informed anticoagulation decisions.
• Identify major valvular lesions and the indications for intervention.
• Diagnose and stage heart failure, selecting the appropriate guideline-directed therapy.
• Manage common arrhythmias, addressing rate and rhythm control along with anticoagulation strategies.

Understanding Heart Failure

Heart failure (HF) is a complex clinical syndrome resulting from any structural or functional impairment of ventricular filling or ejection of blood. It is classified into two main types: systolic heart failure (HFrEF) and diastolic heart failure (HFpEF).

Systolic Heart Failure (HFrEF)

Systolic heart failure is characterized by a reduced ejection fraction (EF), typically defined as an EF of less than 40%. The underlying cause usually involves conditions such as ischemic heart disease, hypertension, or dilated cardiomyopathy. Diagnosis is primarily based on clinical presentation, echocardiography, and laboratory tests.

Diagnosis

The diagnosis of HFrEF includes:

1. Clinical signs: Edema, jugular venous distension, and displaced apex beat.
2. Echocardiography: An EF < 40% confirmed by imaging studies.
3. Biomarkers: Elevated levels of B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP).

Worked Example

Clinical Scenario: A 68-year-old male presents with dyspnea on exertion, peripheral edema, and fatigue. His echocardiogram reveals an ejection fraction of 35%.

• Diagnosis: HFrEF is confirmed due to EF < 40% and clinical presentation.

Diastolic Heart Failure (HFpEF)

Diastolic heart failure is characterized by preserved ejection fraction (EF ≥ 50%) but impaired ventricular filling. It is often seen in older adults, associated with conditions such as hypertension, diabetes, and obesity.

Diagnosis

Key aspects of diagnosing HFpEF include:

1. Clinical signs: Similar to HFrEF but with a preserved EF.
2. Echocardiography: Evidence of diastolic dysfunction, such as abnormal mitral inflow pattern.
3. Biomarkers: Typically not elevated, but may show mild increases in BNP.

Worked Example

Clinical Scenario: A 73-year-old female with a history of hypertension presents with exertional dyspnea and orthopnea. An echocardiogram shows an EF of 55% but reveals signs of diastolic dysfunction.

• Diagnosis: HFpEF based on preserved EF and clinical signs.

Staging Heart Failure

Heart failure can be staged using the New York Heart Association (NYHA) classification:

• Class I: No limitation of physical activity.
• Class II: Slight limitation; comfortable at rest but ordinary activity causes symptoms.
• Class III: Marked limitation; comfortable at rest but minimal exertion causes symptoms.
• Class IV: Inability to carry on any physical activity without discomfort; symptoms may occur at rest.

Furthermore, the American College of Cardiology/American Heart Association (ACC/AHA) stages heart failure from A (at risk for HF) to D (advanced HF requiring specialized interventions).

Guideline-Directed Therapy for Heart Failure

Management includes both pharmacologic and non-pharmacologic strategies. Medications may include:

• ACE inhibitors: Decrease mortality and morbidity in HFrEF.
• Beta-blockers: Improve EF and reduce symptoms in HFrEF.
• Diuretics: Alleviate congestion symptoms in both HFrEF and HFpEF.

Common Misconceptions

• Myth: All heart failure patients have elevated BNP levels.
• Fact: While BNP is often elevated, some HFpEF patients may have normal levels.

Arrhythmias

Arrhythmias are irregular heartbeats that can be classified as tachyarrhythmias (fast heart rates) and bradyarrhythmias (slow heart rates). Understanding common arrhythmias is crucial for effective management.

Atrial Fibrillation (AF)

Atrial fibrillation is the most common sustained arrhythmia and poses significant risks, particularly stroke. It is characterized by an irregularly irregular pulse with no discernible P waves on the electrocardiogram (ECG).

Management of Atrial Fibrillation

1. Rate Control: Often achieved with beta-blockers or calcium channel blockers.
2. Rhythm Control: Can involve antiarrhythmic medications or procedures like cardioversion.
3. Anticoagulation: Based on the CHADS2 or CHA2DS2-VASc scoring system to evaluate stroke risk.

Worked Example

Clinical Scenario: A 75-year-old woman with a history of hypertension and heart failure presents with palpitations. Her ECG reveals atrial fibrillation.

• Management: Assess stroke risk using CHA2DS2-VASc. If the score is 2 or greater, initiate anticoagulation therapy (e.g., warfarin, direct oral anticoagulants).

Bradyarrhythmias

Bradyarrhythmias are heart rates that are less than 60 beats per minute. Common causes may include medication effects, vagal stimulation, or intrinsic cardiac disease.

Management

Treatment focuses on symptom relief; in cases of severe bradycardia, a permanent pacemaker may be necessary.

Valvular Heart Disease

Valvular heart disease involves the dysregulation of one or more heart valves, leading to regurgitation or stenosis. Major types include:

• Aortic Stenosis: Narrowing of the aortic valve opening, affecting blood flow from the heart.
• Mitral Regurgitation: Backward flow of blood through the mitral valve during systole.

Indications for Intervention

Intervention may be indicated based on symptoms, degree of stenosis or regurgitation, and the presence of heart failure. Surgical options may include valve repair or replacement.

Worked Example

Clinical Scenario: A 70-year-old male with exertional dyspnea and a harsh systolic murmur at the second right intercostal space is diagnosed with aortic stenosis.

• Management: Indication for surgical intervention as he has symptomatic severe aortic stenosis.

Conclusion

In conclusion, understanding heart failure, arrhythmias, and valvular disease is essential for the effective management of these common conditions. Accurate diagnosis, classification, and guideline-directed therapy can significantly improve patient outcomes. Also, careful assessment of arrhythmias, particularly atrial fibrillation, is crucial for preventing complications like stroke. As students prepares for the USMLE Step 2 CK, mastering these concepts will form a solid foundation for internal medicine.

Study Notes

• Systolic heart failure (HFrEF) has low ejection fraction; diastolic heart failure (HFpEF) has preserved ejection fraction.
• Use NYHA classification for staging heart failure.
• Anticoagulation in atrial fibrillation based on CHADS2 or CHA2DS2-VASc scores.
• Major valvular diseases include aortic stenosis and mitral regurgitation; assess for surgical intervention based on symptoms and severity.
• Always consider patient's stability and timing in management decisions.